The National Institutes of Health (NIH) awarded Children’s National Hospital nearly $1M of research support toward uncovering the specific cellular response that happens inside a developing brain once it is infected with a virus.

Researchers from Children’s National Hospital developed the first non-muscle targeted gene therapy that enhances diseased muscle fiber repair and improves muscle function.

Children’s National Hospital experts provided a contemporary description of the epidemiology, clinical presentation and management of chronic active Epstein-Barr virus.

Researchers from Children’s National developed a new approach that helped them generate personalized T cells to target and kill tumors.